T1	Participants 0 121	Norfloxacin modulates the inflammatory response and directly affects neutrophils in patients with decompensated cirrhosis
T2	Participants 142 230	Patients with cirrhosis undergoing selective intestinal decontamination with norfloxacin
T3	Participants 367 401	Thirty-one patients with cirrhosis
T4	Participants 587 619	Fifty-nine ascitic fluid samples
